• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毒理病理学论坛*:关于毒性研究中不良和非不良组织病理学发现的认定意见:病理学家的困境

Toxicologic Pathology Forum*: Opinion on Designation of Adverse and Nonadverse Histopathological Findings in Toxicity Studies: The Pathologist's Dilemma.

作者信息

Gopinath Chirukandath, Mowat Vasanthi

机构信息

1 Consultant, Huntingdon, Cambridgeshire, United Kingdom.

2 Covance CRS, Huntingdon, Cambridgeshire, United Kingdom.

出版信息

Toxicol Pathol. 2019 Jul;47(5):564-573. doi: 10.1177/0192623319854040. Epub 2019 Jul 10.

DOI:10.1177/0192623319854040
PMID:31291835
Abstract

In this opinion piece, we discuss some proposed principles for designating adversity and nonadversity of histopathological changes. The suggested approach categorizes the classes of findings noted in toxicity studies with illustrations and examples and suggests adversity or nonadversity for each class, in the authors' opinions, with rationales. Although the suggestions and examples offered in this opinion piece are generally in agreement with Society of Toxicologic Pathology best practices guideline on adversity, the authors suggest and highlight occasional divergences and differences of opinion. This is because making an adversity call is a complex and challenging topic that is difficult to simplify. Some of the challenges in deciding on adversity are discussed, especially those related to making an adversity call on a histopathological finding in isolation, based on the nature and extent of severity. The authors demonstrate some of these situations with examples. Finally, the authors suggest, in contrast to the guidelines, occasional use of a separate category for findings that are less easily classified. *This is an opinion article submitted to the Toxicologic Pathology Forum. It represents the views of the author(s). It does not constitute an official position of the Society of Toxicologic Pathology, British Society of Toxicological Pathology, or European Society of Toxicologic Pathology, and the views expressed might not reflect the best practices recommended by these Societies. This article should not be construed to represent the policies, positions, or opinions of their respective organizations, employers, or regulatory agencies.

摘要

在这篇观点文章中,我们讨论了一些关于确定组织病理学变化的逆境与非逆境的提议原则。所建议的方法对毒性研究中记录的各类发现进行了分类,并配有插图和示例,同时作者依据原理对每一类发现给出了逆境或非逆境的判定。尽管这篇观点文章中提供的建议和示例总体上与毒理病理学会关于逆境的最佳实践指南一致,但作者指出并强调了偶尔存在的分歧和不同观点。这是因为做出逆境判定是一个复杂且具有挑战性的话题,难以简化。文章讨论了在判定逆境时面临的一些挑战,尤其是那些基于严重程度的性质和范围单独对组织病理学发现做出逆境判定时所涉及的挑战。作者通过示例展示了其中一些情况。最后,与指南不同的是,作者建议对于那些不太容易分类的发现,偶尔使用一个单独的类别。*这是一篇提交给毒理病理学论坛的观点文章。它代表作者的观点。它并不构成毒理病理学会、英国毒理病理学会或欧洲毒理病理学会的官方立场,所表达的观点可能并不反映这些学会推荐的最佳实践。本文不应被解释为代表其各自组织、雇主或监管机构的政策、立场或观点。

相似文献

1
Toxicologic Pathology Forum*: Opinion on Designation of Adverse and Nonadverse Histopathological Findings in Toxicity Studies: The Pathologist's Dilemma.毒理病理学论坛*:关于毒性研究中不良和非不良组织病理学发现的认定意见:病理学家的困境
Toxicol Pathol. 2019 Jul;47(5):564-573. doi: 10.1177/0192623319854040. Epub 2019 Jul 10.
2
Toxicologic Pathology Forum*: Commentary on "Opinion on Designation of Adverse and Nonadverse Histopathological Findings in Toxicity Studies: The Pathologist's Dilemma".毒理病理学论坛*:对《关于毒性研究中不良和非不良组织病理学发现的指定意见:病理学家的困境》的评论
Toxicol Pathol. 2019 Jul;47(5):574-576. doi: 10.1177/0192623319840355. Epub 2019 Jul 14.
3
Toxicologic Pathology Forum*: Opinion on Considerations for the Use of Whole Slide Images in GLP Pathology Peer Review.毒理学病理学论坛*:关于在GLP病理学同行评审中使用全切片图像的考量意见
Toxicol Pathol. 2019 Feb;47(2):100-107. doi: 10.1177/0192623318818790. Epub 2019 Jan 13.
4
Toxicologic Pathology Forum*: Opinion on Sexual Maturity and Fertility Assessment in Long-tailed Macaques ( Macaca fascicularis) in Nonclinical Safety Studies.毒理病理学论坛*:关于非临床安全性研究中食蟹猴(猕猴属)性成熟和生育力评估的意见
Toxicol Pathol. 2019 Jun;47(4):444-460. doi: 10.1177/0192623319831009. Epub 2019 Mar 21.
5
Toxicologic Pathology Forum*: Opinion on Integrating Innovative Digital Pathology Tools in the Regulatory Framework.毒理病理学论坛*:关于在监管框架中整合创新数字病理学工具的意见
Toxicol Pathol. 2019 Jun;47(4):436-443. doi: 10.1177/0192623319827485. Epub 2019 Feb 5.
6
Toxicologic Pathology Forum: Current Status on the Use of Animal Models of Human Disease in the Pharmaceutical Industry in Japan in Nonclinical Safety Assessment-Opinion Paper.毒理病理学论坛:日本制药行业在非临床安全性评估中使用人类疾病动物模型的现状——意见书
Toxicol Pathol. 2019 Feb;47(2):108-120. doi: 10.1177/0192623318816669. Epub 2019 Jan 13.
7
Is It Adverse, Nonadverse, Adaptive, or Artifact?它是不良反应、非不良反应、适应性反应还是假象?
Toxicol Pathol. 2017 Jan;45(1):238-247. doi: 10.1177/0192623316672352. Epub 2016 Oct 23.
8
Regulatory forum opinion piece*: pathology peer review--to lock or not to lock, is that really the question?监管论坛观点文章*:病理学同行评审——锁库还是不锁库,这真的是问题所在吗?
Toxicol Pathol. 2013;41(7):1051-2. doi: 10.1177/0192623313501412. Epub 2013 Aug 19.
9
Scientific and Regulatory Policy Committee Points to Consider*: Review of Scientific and Regulatory Policy Committee Points to Consider: Review of Current Practices for Ultrastructural Pathology Evaluations in Support of Nonclinical Toxicology Studies.科学与监管政策委员会需考虑的要点*:科学与监管政策委员会需考虑要点的回顾:支持非临床毒理学研究的超微结构病理学评估现行做法的回顾。
Toxicol Pathol. 2019 Jun;47(4):461-468. doi: 10.1177/0192623319835170. Epub 2019 Apr 24.
10
Regulatory forum opinion piece: thresholds in toxicologic pathology.监管论坛观点文章:毒理病理学中的阈值
Toxicol Pathol. 2012 Oct;40(7):1079-81. doi: 10.1177/0192623312443322. Epub 2012 May 14.